| Veröffentlichte Version Download ( PDF | 980kB) | Lizenz: Creative Commons Namensnennung 4.0 International |
Severe oral mucositis and healthcare utilization in adults with acute lymphoblastic leukemia receiving myeloablative total body irradiation–based conditioning
Artikel
Gruber, Isabella
, Edinger, Matthias
, Poeck, Hendrik
, Meedt, Elisabeth, Weber, Daniela, Holler, Ernst
, Herr, Wolfgang
, Koelbl, Oliver und Wolff, Daniel
(2026)
Severe oral mucositis and healthcare utilization in adults with acute lymphoblastic leukemia receiving myeloablative total body irradiation–based conditioning.
Supportive Care in Cancer 34 (12).
DOI zum Zitieren dieses Dokuments: 10.5283/epub.83200
Zusammenfassung
Purpose We evaluated the association between total body irradiation (TBI) dose and severe oral mucositis (OM) in adults with acute lymphoblastic leukemia (ALL) undergoing myeloablative allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods We analyzed 101 adults receiving 8 or 12 Gy TBI. Severe OM was defined as WHO grades 3–4. TBI allocation was non-randomized, with 8 Gy more ...
Purpose
We evaluated the association between total body irradiation (TBI) dose and severe oral mucositis (OM) in adults with acute lymphoblastic leukemia (ALL) undergoing myeloablative allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Methods
We analyzed 101 adults receiving 8 or 12 Gy TBI. Severe OM was defined as WHO grades 3–4. TBI allocation was non-randomized, with 8 Gy more frequently used in older patients and those with a Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) > 3. Multivariable logistic regression assessed factors associated with severe OM, with the Karnofsky Performance Status (KPS) included in the primary model; sensitivity analyses evaluated alternative models.
Results
Severe OM occurred in 48 patients (47.5%) and was more frequent after 12 than 8 Gy (62.0% vs. 33.3%, P = 0.005). In the primary model, 12 Gy TBI was associated with higher odds of severe OM (OR 2.78, 95% CI 1.17–6.78; P = 0.022). The association between 12 Gy TBI and severe OM remained significant when HCT-CI replaced KPS and after calendar-year adjustment. After age adjustment, the estimate was similar, but the confidence interval widened and included the null (OR 2.63, 95% CI 0.90–8.06; P = 0.081). Severe OM was associated with a 4-day longer median hospital stay (41 vs. 37 days, P = 0.001) and a 5-day longer median duration of systemic therapeutic antibiotic treatment (20 vs. 15 days, P = 0.002). Neither measure differed significantly by TBI dose.
Conclusion
Higher TBI dose was associated with severe OM; severe OM was associated with longer hospital stays and systemic therapeutic antibiotic treatment. Findings should be interpreted cautiously given non-randomized TBI allocation.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | Supportive Care in Cancer | ||||
| Verlag | Springer | ||||
| Open Access Art | DEAL (Springer) | ||||
| Band | 34 | ||||
| Nummer des Zeitschriftenheftes oder des Kapitels | 12 | ||||
| Datum | 18 November 2026 | ||||
| Veröffentlichungsdatum | 19 Nov 2026 05:56 | ||||
| Institutionen | Medizin > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) Medizin > Lehrstuhl für Strahlentherapie Leibniz-Institut für Immuntherapie (LIT) | ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | Oral mucositis · Hematopoietic stem cell transplantation · Total body irradiation · Antibiotic therapy · Hospital stay | ||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Ja | ||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-832000 | ||||
| Dokumenten-ID | 83200 |
Downloadstatistik
Downloadstatistik